1 citations
,
August 2021 in “Journal of Investigative Dermatology” ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.
November 2023 in “Annales de dermatologie et de vénéréologie, FMC” Baricitinib effectively treats severe alopecia for up to 104 weeks.
Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.
September 2017 in “Journal of Investigative Dermatology” Finasteride helps female-pattern hair loss.
research 22
December 2023 in “Psychiatry Neurology and Medical Psychology” September 2025 in “Journal of the American Academy of Dermatology”
October 2023 in “Regular and Young Investigator Award Abstracts” Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.
September 1999 in “Hair transplant forum international” May 2010 in “Europe PMC (PubMed Central)” Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.
3 citations
,
September 2021 in “Journal of Investigative Dermatology” Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.
September 2023 in “Journal of The American Academy of Dermatology” People were generally happy with the home light therapy devices for hair loss.
November 2025 in “SKIN The Journal of Cutaneous Medicine” Baricitinib significantly regrows hair in teens with severe alopecia areata.
4 citations
,
September 2022 in “Journal of The American Academy of Dermatology” Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.
June 2018 in “The Journal of Sexual Medicine” Finasteride helps female-pattern hair loss.
January 2023 in “Springer eBooks”
September 2024 in “Journal of the American Academy of Dermatology” Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.
January 2018 in “The Egyptian Journal of Hospital Medicine” The document's conclusion cannot be provided because the document is not accessible.
September 2023 in “Journal of The American Academy of Dermatology” Patients with skin cancer on the scalp and ear in Mexico have specific features and results from their treatments.
November 2023 in “JEADV Clinical Practice” Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.
July 2005 in “Journal of the American Academy of Dermatology”
July 2017 in “Hair transplant forum international” I'm sorry, but I can't provide a summary as I don't have the content of the document.
June 2023 in “Zenodo (CERN European Organization for Nuclear Research)”
July 1997 in “Hair transplant forum international” The document could not be processed.
January 2024 in “Clinical and Experimental Dermatology” Baricitinib helps treat severe hair loss in people over 65.
November 2010 in “SciVee”
July 2008 in “Hair transplant forum international” The document cannot be understood or processed.
June 2023 in “Zenodo (CERN European Organization for Nuclear Research)”
April 2013 in “e-Competitions Bulletin” In 2013, the FTC settled with hair company Bosley over claims it illegally shared business information with a competitor.
April 2023 in “Journal of Investigative Dermatology” The document's conclusion cannot be provided because the content is not accessible.
September 2022 in “Journal of The American Academy of Dermatology” Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.